Doxorubicinone is a key metabolite of doxorubicin, an anthracycline antitumor antibiotic used in the treatment of various cancers. As the aglycone derivative of this potent chemotherapeutic agent, it is… Read more
Doxorubicinone is a key metabolite of doxorubicin, an anthracycline antitumor antibiotic used in the treatment of various cancers. As the aglycone derivative of this potent chemotherapeutic agent, it is a critical component in analytical research related to anthracycline pharmacology. Laboratories utilize high-quality Doxorubicinone reference standards, including pharmacopeial and non-pharmacopeial impurities, to conduct rigorous impurity profiling and method validation. These compounds, along with stable isotope labelled versions, are essential for pharmaceutical scientists during stability testing, extractables and leachables studies, and quantitative analysis. By providing accurate characterization of this metabolite, analytical chemists can ensure precise quality control throughout the drug development and manufacturing lifecycle. Utilizing these specialized reference materials enables the detection and quantification of related substances, supporting compliance with regulatory standards for pharmaceutical purity and safety in complex oncological formulations.